| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 9 |
| 1 | INSULIN LISPRO | 9 |
| 2 | HUMAN INSULIN | 3 |
| 3 | INSULIN HUMAN | 3 |
| 4 | ADALIMUMAB | 2 |
| 5 | APREMILAST | 2 |
| 6 | ATORVASTATIN CALCIUM | 2 |
| 7 | BISOPROLOL FUMARATE | 2 |
| 8 | BREXPIPRAZOLE | 2 |
| 9 | BRODALUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRODALUMAB | 2 | 0.0010 |
| 1 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 4 | INSULIN LISPRO-AABC | 1 | 0.0005 |
| 5 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 6 | HUMAN INSULIN | 3 | 0.0004 |
| 7 | IRBESARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 8 | BREXPIPRAZOLE | 2 | 0.0001 |
| 9 | TRAVOPROST | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 15 |
| 1 | Insulin [EPC] | 6 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 3 |
| 3 | GLP-1 Receptor Agonist [EPC] | 3 |
| 4 | Prostaglandin Analog [EPC] | 3 |
| 5 | Aldosterone Antagonist [EPC] | 2 |
| 6 | Atypical Antipsychotic [EPC] | 2 |
| 7 | Corticosteroid [EPC] | 2 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 2 |
| 9 | Phosphodiesterase 4 Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 1 | Insulin [EPC] | 6 | 0.0001 |
| 2 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 3 | Insulin Analog [EPC] | 15 | 0.0000 |
| 4 | Prostaglandin Analog [EPC] | 3 | 0.0000 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 2 | 0.0000 |